Jun 18, 2021

Latest Testing Confirms Viraleze Highly Effective Against Alpha, Beta and Gamma COVID Variants

Latest Testing Confirms Viraleze Highly Effective Against Alpha, Beta and Gamma COVID Variants

News18 reports on Starpharma's latest VIRALEZETM announcement: "New data released today shows that Australia’s Viraleze anti-COVID nasal spray is more than 99.9% effective against three of the four deadliest variants of the SARS-CoV-2 virus." Read the full article here.

 This contains certain forward-looking statements.